middle.news
Memphasys Advances Felix™ CE Mark, Boosts Sales in Japan, Validates RoXsta™ Assay
2:45pm on Wednesday 30th of July, 2025 AEST
•
Biotechnology
Read Story
Memphasys Advances Felix™ CE Mark, Boosts Sales in Japan, Validates RoXsta™ Assay
2:45pm on Wednesday 30th of July, 2025 AEST
Key Points
CE Mark submission for Felix™ completed; approval expected within 6–12 months
Direct sales launched in Japan, New Zealand, UAE, and Canada with repeat sales in Japan
RoXsta™ Mega Cell assay validated for high-throughput fertility and veterinary testing
$1.275 million capital raise supports regulatory filings and commercial expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE